SCHEMBL641432

SCHEMBL641432

NC(CCC(=O)O)C(=O)OP(=O)(O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM3 Q14832 3/20 0.52
GRM8 O00222 2/20 0.52
GRM6 O15303 2/20 0.52
GRM7 Q14831 2/20 0.52
GRM4 Q14833 2/20 0.52
GRIN2D O15399 1/20 0.52
GRIN3B O60391 1/20 0.52
GSR P00390 1/20 0.52
CYP1A2 P05177 1/20 0.52
GRIK1 P39086 1/20 0.52
GRM5 P41594 1/20 0.52
GRIA1 P42261 1/20 0.52
GRIA2 P42262 1/20 0.52
GRIA3 P42263 1/20 0.52
SLC1A3 P43003 1/20 0.52
SLC1A2 P43004 1/20 0.52
SLC1A1 P43005 1/20 0.52
GRIA4 P48058 1/20 0.52
GRIN1 Q05586 1/20 0.52
GRIN2A Q12879 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12189719 1.00 GRM3 (0.52) GRM3GRM8GRM6GRM7GRM4
SCHEMBL641431 1.00 GRM3 (0.52) GRM3GRM8GRM6GRM7GRM4
SCHEMBL13176585 0.85 PEPD (0.39) GRM3GRM8GRM6GRM7GRM4
SCHEMBL2351136 0.85 ALOX15 (0.50) GRM3GRM8GRM6GRM7GRM4
SCHEMBL3659563 0.85 CA4 (0.37) GRM3GRM8GRM6GRM7GRM4
SCHEMBL28137272 0.85 ALOX15 (0.50) GRM3GRM8GRM6GRM7GRM4
SCHEMBL4751449 0.85 CA4 (0.37) GRM3GRM8GRM6GRM7GRM4
Ammonia Solution, Strong SCHEMBL28656082 0.83 CA4 (0.35) GRM3GRM8GRM6GRM7GRM4
SCHEMBL10671206 0.83 CA4 (0.35) GRM3GRM8GRM6GRM7GRM4
Water SCHEMBL27732866 0.83 CA4 (0.35) GRM3GRM8GRM6GRM7GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12480131-B2 Tropane alkaloid (TA) producing non-plant host cells, and methods of making and using the same THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2025-11-25 US claimed
US-20250221954-A1 METHODS TO TREAT, PREVENT, OR REDUCE HYPERAMMONEMIA RUBIN DARREN ALEXANDER (US) 2025-07-10 US claimed
EP-4314301-A1 TROPANE ALKALOID TRANSPORTERS AND METHODS OF MAKING TROPANE ALKALOIDS USING THE SAME The Board of Trustees of the Leland Stanford Junior University (US) 2024-02-07 EP claimed
WO-2022204283-A1 TROPANE ALKALOID TRANSPORTERS AND METHODS OF MAKING TROPANE ALKALOIDS USING THE SAME THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2022-09-29 WO claimed
US-12522842-B2 Glutamine synthetase mutant having glufosinate resistance and application thereof and cultivation method therefor GEVOTO LLC (CN) 2026-01-13 US disclosed
EP-4647496-A1 NOVEL PROMOTER AND USE THEREOF CJ CheilJedang Corporation (KR) 2025-11-12 EP disclosed
US-20250277226-A1 IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER EVONIK OPERATIONS GMBH (DE) 2025-09-04 US disclosed
US-20250221954-A1 METHODS TO TREAT, PREVENT, OR REDUCE HYPERAMMONEMIA RUBIN DARREN ALEXANDER (US) 2025-07-10 US disclosed
US-20250171790-A1 METHOD FOR THE FERMENTATIVE PRODUCTION OF GUANIDINOACETIC ACID EVONIK OPERATIONS GMBH (DE) 2025-05-29 US disclosed
CN-119768521-A Novel promoter and application thereof CJ第一制糖株式会社 2025-04-04 CN disclosed
US-12065677-B2 Method for the fermentative production of guanidinoacetic acid EVONIK OPERATIONS GMBH (DE) 2024-08-20 US disclosed
US-11999982-B2 Method for the fermentative production of guanidinoacetic acid EVONIK OPERATIONS GMBH (DE) 2024-06-04 US disclosed
WO-2001053323-A2 PLANTS TOLERANT OF ENVIRONMENTAL STRESS CONDITIONS, METHODS OF GENERATING SAME AND NOVEL POLYNUCLEOTIDE SEQUENCE UTILIZED THEREBY RAMOT UNIVERSITY AUTHORITY FOR APPLIED RESEARCH & INDUSTRIAL DEVELOPMENT LTD. (IL) 2001-07-26 WO disclosed
WO-2001040268-A2 BERYLLOFLUORIDE ANALOGUES OF ACYL PHOSPHATE POLYPEPTIDES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-06-07 WO disclosed
EP-1066309-A1 LIBRARIES OF EXPRESSIBLE GENE SEQUENCES INVITROGEN CORPORATION (US) 2001-01-10 EP disclosed
CN-1258736-A Process for producing L--arginine AJINOMOTO KK (JP) 2000-07-05 CN disclosed
WO-1999051620-A1 LIBRARIES OF EXPRESSIBLE GENE SEQUENCES INVITROGEN CORPORATION (US) 1999-10-14 WO disclosed
US-5695960-A Hippuricase gene CHAN VOON LOONG (CA) 1997-12-09 US disclosed
US-5639950-A GENETIC ENGINEERING THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1997-06-17 US disclosed
US-5344923-A Improved salt and drought resistance for plants THE OHIO STATE UNIVERSITY RESEARCH FOUNDATION (US) 1994-09-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250277226-A1 IMPROVED BIOTECHNOLOGICAL METHOD FOR PRODUCING GUANIDINO ACETIC ACID (GAA) BY INACTIVATION OF AN AMINO ACID EXPORTER GDA, GAA, AGXT GRM3 941/4885GRM8 1241/4885GRM6 795/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.